Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Heritable DNA methylation marks associated with susceptibility to breast cancer.

Joo JE, Dowty JG, Milne RL, Wong EM, Dugué PA, English D, Hopper JL, Goldgar DE, Giles GG, Southey MC; kConFab.

Nat Commun. 2018 Feb 28;9(1):867. doi: 10.1038/s41467-018-03058-6.

2.

Precision oncology using a clinician-directed, tailored approach to molecular profiling.

Lam M, Tran B, Beck S, Tie J, Herath D, Whittle J, Kwan EM, Fox SB, Fellowes A, Ananda S, Lipton L, Gibbs P, Rosenthal MA, Desai J.

Asia Pac J Clin Oncol. 2018 Feb;14(1):84-90. doi: 10.1111/ajco.12787. Epub 2017 Oct 30.

PMID:
29083093
3.

Maternal Lifetime Trauma Exposure, Prenatal Cortisol, and Infant Negative Affectivity.

Enlow MB, Devick KL, Brunst KJ, Lipton LR, Coull BA, Wright RJ.

Infancy. 2017 Jul-Aug;22(4):492-513. doi: 10.1111/infa.12176. Epub 2017 Jan 20.

PMID:
28983193
4.

Associations among prenatal stress, maternal antioxidant intakes in pregnancy, and child temperament at age 30 months.

Lipton LR, Brunst KJ, Kannan S, Ni YM, Ganguri HB, Wright RJ, Bosquet Enlow M.

J Dev Orig Health Dis. 2017 Dec;8(6):638-648. doi: 10.1017/S2040174417000411. Epub 2017 Jun 27.

PMID:
28651674
5.

Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Abou-Alfa GK, Blanc JF, Miles S, Ganten T, Trojan J, Cebon J, Liem AK, Lipton L, Gupta C, Wu B, Bass M, Hollywood E, Ma J, Bradley M, Litten J, Saltz LB.

Oncologist. 2017 Jul;22(7):780-e65. doi: 10.1634/theoncologist.2017-0058. Epub 2017 Jun 7.

6.

How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?

Au L, Turner N, Wong HL, Field K, Lee B, Boadle D, Cooray P, Karikios D, Kosmider S, Lipton L, Nott L, Parente P, Tie J, Tran B, Wong R, Yip D, Shapiro J, Gibbs P.

Asia Pac J Clin Oncol. 2018 Apr;14(2):e167-e174. doi: 10.1111/ajco.12671. Epub 2017 Mar 16.

PMID:
28299879
7.

Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L.

Lorgelly PK, Doble B, Rowen D, Brazier J; Cancer 2015 investigators.

Qual Life Res. 2017 May;26(5):1163-1176. doi: 10.1007/s11136-016-1443-y. Epub 2016 Nov 9.

8.

Prevalence of systemic anticancer therapy for patients within the last 30 days of life: experience in a private hospital oncology group.

Wein L, Rowe C, Brady B, Handolias D, Lipton L, Pook D, Stanley R, Haines I.

Intern Med J. 2017 Mar;47(3):280-283. doi: 10.1111/imj.13260.

PMID:
27658500
9.

Impact of Maternal Lifetime Interpersonal Trauma on Children's Asthma: Mediation Through Maternal Active Asthma During Pregnancy.

Brunst KJ, Rosa MJ, Jara C, Lipton LR, Lee A, Coull BA, Wright RJ.

Psychosom Med. 2017 Jan;79(1):91-100. doi: 10.1097/PSY.0000000000000354.

10.

TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer.

Ferraro D, Goldstein D, O'Connell RL, Zalcberg JR, Sjoquist KM, Tebbutt NC, Grimison P, McLachlan S, Lipton LL, Vasey P, Gebski VJ, Aiken C, Cronk M, Ng S, Karapetis CS, Shannon J; behalf of the the Australasian Gastro-Intestinal Trials Group.

Cancer Chemother Pharmacol. 2016 Aug;78(2):361-7. doi: 10.1007/s00280-016-3089-4. Epub 2016 Jun 22.

PMID:
27335026
11.

Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.

Pavlakis N, Sjoquist KM, Martin AJ, Tsobanis E, Yip S, Kang YK, Bang YJ, Alcindor T, O'Callaghan CJ, Burnell MJ, Tebbutt NC, Rha SY, Lee J, Cho JY, Lipton LR, Wong M, Strickland A, Kim JW, Zalcberg JR, Simes J, Goldstein D.

J Clin Oncol. 2016 Aug 10;34(23):2728-35. doi: 10.1200/JCO.2015.65.1901. Epub 2016 Jun 20.

12.

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.

Hammel P, Huguet F, van Laethem JL, Goldstein D, Glimelius B, Artru P, Borbath I, Bouché O, Shannon J, André T, Mineur L, Chibaudel B, Bonnetain F, Louvet C; LAP07 Trial Group.

JAMA. 2016 May 3;315(17):1844-53. doi: 10.1001/jama.2016.4324.

PMID:
27139057
13.

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.

Wang-Gillam A, Li CP, Bodoky G, Dean A, Shan YS, Jameson G, Macarulla T, Lee KH, Cunningham D, Blanc JF, Hubner RA, Chiu CF, Schwartsmann G, Siveke JT, Braiteh F, Moyo V, Belanger B, Dhindsa N, Bayever E, Von Hoff DD, Chen LT; NAPOLI-1 Study Group.

Lancet. 2016 Feb 6;387(10018):545-57. doi: 10.1016/S0140-6736(15)00986-1. Epub 2015 Nov 29. Erratum in: Lancet. 2016 Feb 6;387(10018):536.

PMID:
26615328
14.

Realising the Value of Linked Data to Health Economic Analyses of Cancer Care: A Case Study of Cancer 2015.

Lorgelly PK, Doble B, Knott RJ; Cancer 2015 Investigators.

Pharmacoeconomics. 2016 Feb;34(2):139-54. doi: 10.1007/s40273-015-0343-2.

PMID:
26547307
15.

"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic.

Parisot JP, Thorne H, Fellowes A, Doig K, Lucas M, McNeil JJ, Doble B, Dobrovic A, John T, James PA, Lipton L, Ashley D, Hayes T, McMurrick P, Richardson G, Lorgelly P, Fox SB, Thomas DM.

J Pers Med. 2015 Oct 29;5(4):354-69. doi: 10.3390/jpm5040354.

16.

Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma.

Gibbs P, Do C, Lipton L, Cade DN, Tapner MJ, Price D, Bower GD, Dowling R, Lichtenstein M, van Hazel GA.

BMC Cancer. 2015 Oct 26;15:802. doi: 10.1186/s12885-015-1822-8.

17.

A prospective study of appetite and food craving in 30 patients with Cushing's disease.

Geer EB, Lalazar Y, Couto LM, Cohen V, Lipton LR, Shi W, Bagiella E, Conwell I, Bederson J, Kostadinov J, Post KD, Freda PU.

Pituitary. 2016 Apr;19(2):117-26. doi: 10.1007/s11102-015-0690-1.

18.

Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine.

Thomas DM, Fox S, Lorgelly PK, Ashley D, Richardson G, Lipton L, Parisot JP, Lucas M, McNeil J, Wright M; Cancer 2015 Investigators.

Drug Discov Today. 2015 Dec;20(12):1429-32. doi: 10.1016/j.drudis.2015.10.009. Epub 2015 Oct 19.

PMID:
26494144
19.

Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.

Jorissen RN, Christie M, Mouradov D, Sakthianandeswaren A, Li S, Love C, Xu ZZ, Molloy PL, Jones IT, McLaughlin S, Ward RL, Hawkins NJ, Ruszkiewicz AR, Moore J, Burgess AW, Busam D, Zhao Q, Strausberg RL, Lipton L, Desai J, Gibbs P, Sieber OM.

Br J Cancer. 2015 Sep 15;113(6):979-88. doi: 10.1038/bjc.2015.296. Epub 2015 Aug 25.

20.

Familial colorectal cancer.

Lung MS, Trainer AH, Campbell I, Lipton L.

Intern Med J. 2015 May;45(5):482-91. doi: 10.1111/imj.12736.

PMID:
25955461

Supplemental Content

Loading ...
Support Center